90 related articles for article (PubMed ID: 26440968)
1. Hydrophobic pocket targeting probes for enteroviruses.
Martikainen M; Salorinne K; Lahtinen T; Malola S; Permi P; Häkkinen H; Marjomäki V
Nanoscale; 2015 Nov; 7(41):17457-67. PubMed ID: 26440968
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Albumin and Endosomal Ions Prime Enterovirus Particles for Uncoating That Can Be Prevented by Fatty Acid Saturation.
Ruokolainen V; Domanska A; Laajala M; Pelliccia M; Butcher SJ; Marjomäki V
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189702
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
[TBL] [Abstract][Full Text] [Related]
4. Early Entry Events in Echovirus 30 Infection.
Vandesande H; Laajala M; Kantoluoto T; Ruokolainen V; Lindberg AM; Marjomäki V
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295914
[TBL] [Abstract][Full Text] [Related]
5. Slow Infection due to Lowering the Amount of Intact versus Empty Particles Is a Characteristic Feature of Coxsackievirus B5 Dictated by the Structural Proteins.
Turkki P; Laajala M; Stark M; Vandesande H; Sallinen-Dal Maso H; Shroff S; Sävneby A; Galitska G; Lindberg AM; Marjomäki V
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375587
[TBL] [Abstract][Full Text] [Related]
6. Infectious Entry Pathway of Enterovirus B Species.
Marjomäki V; Turkki P; Huttunen M
Viruses; 2015 Dec; 7(12):6387-99. PubMed ID: 26690201
[TBL] [Abstract][Full Text] [Related]
7. Coxsackievirus A9 infects cells via nonacidic multivesicular bodies.
Huttunen M; Waris M; Kajander R; Hyypiä T; Marjomäki V
J Virol; 2014 May; 88(9):5138-51. PubMed ID: 24574401
[TBL] [Abstract][Full Text] [Related]
8. Raman spectroscopic signatures of echovirus 1 uncoating.
Ruokola P; Dadu E; Kazmertsuk A; Häkkänen H; Marjomäki V; Ihalainen JA
J Virol; 2014 Aug; 88(15):8504-13. PubMed ID: 24850734
[TBL] [Abstract][Full Text] [Related]
9. Exploring Strategies for Labeling Viruses with Gold Nanoclusters through Non-equilibrium Molecular Dynamics Simulations.
Pohjolainen E; Malola S; Groenhof G; Häkkinen H
Bioconjug Chem; 2017 Sep; 28(9):2327-2339. PubMed ID: 28806062
[TBL] [Abstract][Full Text] [Related]
10. Site-specific targeting of enterovirus capsid by functionalized monodisperse gold nanoclusters.
Marjomäki V; Lahtinen T; Martikainen M; Koivisto J; Malola S; Salorinne K; Pettersson M; Häkkinen H
Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1277-81. PubMed ID: 24474748
[TBL] [Abstract][Full Text] [Related]
11. [The role of the neonatal FC receptor in the uncoating of echoviruses and coxsackievirus A9.].
Usoltseva PS; Alimov AV; Rezaykin AV; Sergeev AG; Novoselov AV
Vopr Virusol; 2019; 64(3):132-139. PubMed ID: 31622060
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Mechanisms of
Laajala M; Kalander K; Consalvi S; Amamuddy OS; Bishop ÖT; Biava M; Poce G; Marjomäki V
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986888
[TBL] [Abstract][Full Text] [Related]
13. Structural Studies Reveal that Endosomal Cations Promote Formation of Infectious Coxsackievirus A9 A-Particles, Facilitating RNA and VP4 Release.
Domanska A; Plavec Z; Ruokolainen V; Löflund B; Marjomäki V; Butcher SJ
J Virol; 2022 Dec; 96(24):e0136722. PubMed ID: 36448797
[TBL] [Abstract][Full Text] [Related]
14. A Novel Open and Infectious Form of Echovirus 1.
Myllynen M; Kazmertsuk A; Marjomäki V
J Virol; 2016 Aug; 90(15):6759-70. PubMed ID: 27194757
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of a specific capsid binder resistance caused by mutations outside the binding pocket.
Braun H; Kirchmair J; Williamson MJ; Makarov VA; Riabova OB; Glen RC; Sauerbrei A; Schmidtke M
Antiviral Res; 2015 Nov; 123():138-45. PubMed ID: 26391975
[TBL] [Abstract][Full Text] [Related]
16. Variability in the integrity of human enteroviruses exposed to various simulated in vivo environments.
Piirainen L; Hovi T; Roivainen M
Microb Pathog; 1998 Sep; 25(3):131-7. PubMed ID: 9790872
[TBL] [Abstract][Full Text] [Related]
17. MOPS and coxsackievirus B3 stability.
Carson SD; Hafenstein S; Lee H
Virology; 2017 Jan; 501():183-187. PubMed ID: 27940223
[TBL] [Abstract][Full Text] [Related]
18. Competition binding studies with biotinylated echovirus 11 in cytofluorimetry analysis.
Mbida AD; Pozzetto B; Sabido O; Akono Y; Grattard F; Habib M; Gaudin OG
J Virol Methods; 1991; 35(2):169-76. PubMed ID: 1667786
[TBL] [Abstract][Full Text] [Related]
19. Human Neonatal Fc Receptor Is the Cellular Uncoating Receptor for Enterovirus B.
Zhao X; Zhang G; Liu S; Chen X; Peng R; Dai L; Qu X; Li S; Song H; Gao Z; Yuan P; Liu Z; Li C; Shang Z; Li Y; Zhang M; Qi J; Wang H; Du N; Wu Y; Bi Y; Gao S; Shi Y; Yan J; Zhang Y; Xie Z; Wei W; Gao GF
Cell; 2019 May; 177(6):1553-1565.e16. PubMed ID: 31104841
[TBL] [Abstract][Full Text] [Related]
20. Antiviral treatment of Coxsackie B virus infection in human pancreatic islets.
Berg AK; Olsson A; Korsgren O; Frisk G
Antiviral Res; 2007 Apr; 74(1):65-71. PubMed ID: 17239967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
